Advancing Research to Treat, Cure, and Prevent Vision Loss
A blinding disease is life-altering, impacting your quality of life and independence. Advancing Sight Network created the Precision Ocular Biobank so we can be part of the cure. Without research today, there will be no cures tomorrow.
Thank you to the organizations supporting our work to restore eyesight through medical research. Alpha Foundation, Community Foundation of Northeast Alabama, The Caring Foundation, Eyesight Foundation of Alabama
blind across the globe
Alabamians with severe & irreversible vision loss
visually impaired across the globe
BIRMINGHAM, Ala. — August 2020 — Two Alabama-based organizations are partnering to find cures for common diseases that cause blindness for millions of people worldwide. In an effort to help medical researchers develop new treatments and cures for blinding eye...
A Registered Biobank Member of
Introduces a new resource to accelerate therapies and cures for eye diseases
Made possible with a generous grant from Alpha Foundation, Inc.
Improving the Human Condition Through Grants to Educational, Scientific and Charitable Organizations
- Genetic screening for 25 genes and 39 variants on eye donors
- SNPs associated with risk/protective effects in Fuch’s Dystrophy, AMD and Glaucoma – Diseases causing vision loss in > 30 million
- Custom designed, multiple disease pathway gene panel created with input from leading experts in Academia and Industry
- Next Generation Sequencing (NGS) powered by TargetRich™ of
A new resource for helping patients with vision-threatening diseases
Responding to the critical shortage of high-quality human eye research tissue to support medical research, the Advancing Sight Network developed the Precision Ocular Biobank. An innovative program that allows patients to sign up to a database, knowing that when they pass, their eyes will be used in high-impact scientific studies to better understand the human vision and combat eye diseases that cause vision loss. The eye tissues provided to researchers will be accompanied by comprehensive medical information and detailed analysis of the tissue, including ocular imaging.
“The state-of-the-art equipment in our Precision Ocular Biobank is used to image, process and preserve the eye tissue – giving researchers the highest quality tissues samples required for their exacting studies. The goal is the acceleration of the development of new cures for diseases such as AMD, diabetic retinopathy and glaucoma.”
Dr. Gregory Grossman
Chief Scientific Officer
Dr. Gregory Grossman has over 18 years of clinical and research experience and serves as the Chief Scientific Officer at the Advancing Sight, providing administrative leadership and scientific oversight for the Precision Ocular Biobank. He received his biomedical PhD with honors in neuroscience from Kent State University and completed a fellowship in retinal disorders at the Cleveland Clinic’s Cole Eye Institute. He has authored numerous articles, book chapters and has been a sponsored presenter at symposiums throughout the world. Gregory has a broad range of experience in ophthalmology, having expertise in both anterior and posterior ocular diseases. He also has experience in eye banking, having managed clinical operations of the Cleveland Eye Bank, and serving as the Director of Research for a large eye banking system. Gregory holds certifications in eye banking (CEBT) and conducting clinical trials (CCRP), and is board certified in Medical Affairs (BCMAS). He is a member of the American Society of Cataract and Refractive Surgery, the Association for Research in Vision and Ophthalmology, the Eye Bank Association of America, International Society for Biological and Environmental Repositories, the Society of Clinical Research Associates and serves on the Scientific Programs Committee of the Eye Banking Association of America and Fight For Sight Scientific Review Committee.